vedolizumab
1 product
3 abstracts
1 target
Target
alpha4beta7 integrinAbstract
Randomized clinical trial of infliximab versus vedolizumab for immune checkpoint inhibitor related colitis.Org: The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation Rsch, Houston, TX, Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, Division of Cancer Medicine, Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX,
Abstract
Immune checkpoint inhibitor-associated gastrointestinal adverse events in patients with colorectal cancer.Org: The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation Rsch, Houston, TX, The University of Texas Health Science Center at Houston,
Abstract
Effect of fecal transplantation on patients’ reported outcome after immune checkpoint inhibitor colitis.Org: MD Anderson Cancer Center, The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation Rsch, Houston, TX, University of Texas MD Anderson Cancer Center, Department of Symptom Research, University of Texas at MD Anderson Cancer Center,
Product
vedolizumab